Paediatric Y_UW1_S M_AA1_R_K_AH0_T_IH0_NG authorisations    PUMA    AA1_R G_R_AE1_N_T_AH0_D B_AY1 DH_AH0 European Medicines Agency    EMA    F_AO1_R M_EH1_D_AH0_K_AH0_L P_R_AA1_D_AH0_K_T_S DH_AE1_T AA1_R IH2_N_T_EH1_N_D_IH0_D IH0_K_S_K_L_UW1_S_IH0_V_L_IY0 F_AO1_R paediatric Y_UW1_S    DH_AE1_T IH1_Z    F_AO1_R Y_UW1_S IH0_N P_EY1_SH_AH0_N_T_S Y_AH1_NG_G_ER0 DH_AE1_N 18 Y_IH1_R_Z Like AO1_R_D_AH0_N_EH2_R_IY0 EMA M_AA1_R_K_AH0_T_IH0_NG authorisations    AH0 PUMA AH0_P_R_UW1_V_AH0_L IH1_Z V_AE1_L_IH0_D IH0_N AO1_L K_AH1_N_T_R_IY0_Z AH1_V DH_AH0 European Economic Area    DH_AH0 European Union AE1_Z W_EH1_L AE1_Z Iceland    Liechtenstein AH0_N_D Norway The PUMA P_R_AA1_S_EH2_S W_AA1_Z IH0_S_T_AE1_B_L_IH0_SH_T T_UW1 M_EY1_K IH1_T M_AO1_R P_R_AA1_F_AH0_T_AH0_B_AH0_L F_AO1_R F_AA2_R_M_AH0_S_UW1_T_IH0_K_AH0_L K_AH1_M_P_AH0_N_IY2_Z T_UW1 M_AA1_R_K_AH0_T D_R_AH1_G_Z F_AO1_R CH_IH1_L_D_R_AH0_N For DH_IH1_S P_ER1_P_AH0_S    N_UW1 D_EY1_T_AH0 Y_UW1_Z_D F_AO1_R PUMA AH0_P_R_UW1_V_D D_R_AH1_G_Z AA1_R P_R_AH0_T_EH1_K_T_IH0_D F_AO1_R 10 Y_IH1_R_Z    AH0_N_D DH_AH0 AE2_P_L_AH0_K_EY1_SH_AH0_N_Z AA1_R P_AA1_R_SH_AH0_L_IY0 IH0_G_Z_EH1_M_P_T F_R_AH1_M F_IY1_Z    In September 2011    DH_AH0 F_ER1_S_T D_R_AH1_G W_AA1_Z AH0_P_R_UW1_V_D AH1_N_D_ER0 DH_IH1_S P_R_AA1_S_EH2_S It W_AA1_Z Buccolam    AH0 B_Y_UW1_K_AH0_L AE2_P_L_AH0_K_EY1_SH_AH0_N F_AO1_R_M AH1_V midazolam F_AO1_R DH_AH0 T_R_IY1_T_M_AH0_N_T AH1_V S_IY1_ZH_ER0_Z     